4//SEC Filing
Jacobs Jeffrey W 4
Accession 0001567619-21-012329
CIK 0001437402other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 4:32 PM ET
Size
9.0 KB
Accession
0001567619-21-012329
Insider Transaction Report
Form 4
ARDELYX, INC.ARDX
Jacobs Jeffrey W
VP, Chemistry
Transactions
- Exercise/Conversion
Common Stock
2021-06-15$0.54/sh+7,500$4,050→ 131,551 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-06-15−7,500→ 10,000 totalExercise: $0.54Exp: 2021-08-11→ Common Stock (7,500 underlying) - Sale
Common Stock
2021-06-15$7.29/sh−7,500$54,659→ 124,051 total
Footnotes (3)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 10, 2021.
- [F2]This transaction was executed in multiple trades in prices ranging from $7.242 to $7.41, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]The option, which was granted on August 11, 2011 and has an expiration date of August 11, 2021, is fully vested and exercisable.
Documents
Issuer
ARDELYX, INC.
CIK 0001437402
Entity typeother
Related Parties
1- filerCIK 0001611193
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 4:32 PM ET
- Size
- 9.0 KB